The global oncolytic virotherapy market was valued at USD 20.6 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 26.4% from 2024 to 2030. The rising prevalence of cancer and growing demand for gene therapy are the major factors driving the market for onco... Read More »
February 2024The global oxytocin market is expected to grow at a CAGR of 6.1% from 2024 to 2030. Major factors contributing to the market growth include a rising incidence of pregnancy complications, a global increase in childbirth rates, and a growing awareness of induced labor and breastfeeding. Fo... Read More »
February 2024The global anticoagulants market size was valued at USD 34.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.74% from 2024 to 2030. The rising prevalence of cardiovascular diseases, such as deep vein thrombosis, pulmonary embolism, and atrial fibrilla... Read More »
February 2024The Canada Pharmaceutical market size was estimated at USD 48.59 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.88% over the forecast period. The market is driven by several factors, including an aging population, increasing healthcare expenditures, ... Read More »
February 2024The global ophthalmic drugs market size was estimated at USD 37.82 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.34% from 2024 to 2030. The market growth is attributed to rising prevalence of retinal disorders, advancement in drug delivery, and an ... Read More »
January 2024The U.S. minor cannabinoids market size was estimated at USD 11.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.0% from 2024 to 2030. Consumers have access to a wide range of products containing minor cannabinoids, which cater to their specific hea... Read More »
January 2024The global asthma therapeutics market size was estimated at USD 26.41 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% from 2024 to 2030. The global increase in the prevalence of asthma has significantly raised the demand for therapeutics, includi... Read More »
January 2024The global postpartum health supplements market was valued at USD 1.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. The increasing prevalence of postnatal depression and the introduction of innovative products by the key play... Read More »
January 2024The global biomarkers market size was estimated at USD 81.04 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 13.36% from 2024 to 2030. The rising prevalence of cancer, significance of companion diagnostics, investments in research, and significant innov... Read More »
January 2024The global mineral supplements market size was estimated at USD 16.08 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2030. The growing adoption of mineral supplements to manage chronic conditions cancer, osteoporosis, anemia, and osteoporosis is anticipated to dr... Read More »
January 2024The global pulmonary arterial hypertension market size was valued at USD 7.66 billion in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2030. The growth of market is majorly attributed to increasing support from government & healthcare auth... Read More »
January 2024The global human growth hormone market size was valued at USD 6.32 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2030. The market is experiencing expansion due to factors such as the growing awareness of growth hormones and its incr... Read More »
January 2024The global bioanalytical testing services market was valued at USD 4.33 billion in 2023 and is anticipated to grow at a CAGR of 9.0% over the forecast period. Increasing drug development and approval processes, increasing complexity of therapeutics, and rise in outsourcing of testing ser... Read More »
January 2024The global clinical laboratory tests market size was estimated at USD 114.63 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2030. The clinical laboratory tests market is witnessing growth due to factors such as the rising geriatric po... Read More »
January 2024The global complementary and alternative medicine market size was valued at USD 144.68 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 25.3% from 2024 to 2030. The growing awareness regarding Complementary and Alternative Medicine (CAM), increasing disp... Read More »
January 2024The global legal marijuana market size was valued at USD 21.0 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 25.7% from 2024 to 2030. Increasing demand for legal marijuana is a major factor in growth of the market. Recently, many countries have legali... Read More »
January 2024The global cannabidiol market size was valued at USD 7.71 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.8% from 2024 to 2030. The CBD market size is expected to grow with the increasing legalization of hemp-based products. Companies are developing ... Read More »
January 2024The global progesterone market size was valued at USD 1.15 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 13.1% from 2024 to 2030. Progesterone is prescribed to a patient on a daily or bi-weekly basis for applications not limited to amenorrhea, abnorma... Read More »
January 2024The global biguanides market size was valued at USD 5.10 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of over 3.8% from 2024 to 2030. The growing prevalence of diabetes is the primary reason for the growth of the biguanides market. Biguanides are mostly... Read More »
January 2024The global ear infection treatment market size was valued at USD 11.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.33% from 2024 to 2030. Advancements in continuous renal replacement therapy (CRRT) availability, especially in corporate and private... Read More »
January 2024